March 04, 2015 7:53 AM ET


Company Overview of Neurion Pharmaceuticals, Inc.

Executive Profile

Curt LaBelle M.D.

Director of Business Development, Neurion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships


Dr. Curt LaBelle, M.D. is a Partner at Tullis Health Investors Inc. Dr. LaBelle served as a General Partner at Tullis Health Investors Inc. He was a Managing Director and Partner at the firm. Dr. LaBelle rejoined Tullis in 2008 and previously worked at the firm from 2002 to 2005 as a Senior Associate. Dr. LaBelle has worked in the health care field for 14 years and has ten years of growth and venture capital experience. He served as a Vice President at Investor Growth ...

Corporate Headquarters

1 West Mountain Street
Pasadena, California 91103

United States

Phone: 626-791-0011
Fax: 626-628-0302

Board Members Memberships

Former Director
Former Director
Chairman and Member of Compensation Committee


Columbia University
Columbia University
Brigham Young University
Brigham Young University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neurion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at